NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB)

CUSIP: 63937X103

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / COM
Total 13F shares
10,256,969
Share change
+484,655
Total reported value
$1,415,138
Price per share
$0.14
Number of holders
35
Value change
+$81,465
Number of buys
12
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 63937X103?
CUSIP 63937X103 identifies NAVB - NAVIDEA BIOPHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) as of Q1 2019

As of 31 Mar 2019, NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,256,969 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, WEDBUSH SECURITIES INC, Allred Capital Management, LLC, CITADEL ADVISORS LLC, NORTHERN TRUST CORP, Virtu Financial LLC, and MORGAN STANLEY. This page lists 35 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.